A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers (Q66082614)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers |
clinical trial |
Statements
A Subject-blind, Investigator-blind, Randomized, Placebo-controlled, First-in-human Study Evaluating the Safety/Tolerability, Pharmacokinetics, Effect on Transglutaminase 2 Expression, and Occupancy of Single Ascending Intravenous and Subcutaneous Doses of UCB7858 in Healthy Subjects (English)
0 references
11 July 2016
0 references
31 January 2018
0 references
78
0 references
18 year
0 references
55 year
0 references